116 related articles for article (PubMed ID: 20033802)
21. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
[TBL] [Abstract][Full Text] [Related]
22. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T; Liu L
Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
[TBL] [Abstract][Full Text] [Related]
23. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes.
Yu J; Steck AK; Babu S; Yu L; Miao D; McFann K; Hutton J; Eisenbarth GS; Klingensmith G
J Clin Endocrinol Metab; 2009 Feb; 94(2):504-10. PubMed ID: 19050058
[TBL] [Abstract][Full Text] [Related]
24. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
Biyasheva A; Legro RS; Dunaif A; Urbanek M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2617-25. PubMed ID: 19351735
[TBL] [Abstract][Full Text] [Related]
25. Common coding variant in the TCF7L2 gene and study of the association with type 2 diabetes in Japanese subjects.
Kunika K; Tanahashi T; Numata S; Ueno SI; Ohmori T; Nakamura N; Tsugawa K; Miyawaki K; Moritani M; Inoue H; Itakura M
J Hum Genet; 2008; 53(11-12):972-982. PubMed ID: 19012045
[TBL] [Abstract][Full Text] [Related]
26. Islet specific Wnt activation in human type II diabetes.
Lee SH; Demeterco C; Geron I; Abrahamsson A; Levine F; Itkin-Ansari P
Exp Diabetes Res; 2008; 2008():728763. PubMed ID: 19165345
[TBL] [Abstract][Full Text] [Related]
27. Geniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway.
Yao DD; Yang L; Wang Y; Liu C; Wei YJ; Jia XB; Yin W; Shu L
Cell Death Dis; 2015 May; 6(5):e1746. PubMed ID: 25950476
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.
Weise A; Bruser K; Elfert S; Wallmen B; Wittel Y; Wöhrle S; Hecht A
Nucleic Acids Res; 2010 Apr; 38(6):1964-81. PubMed ID: 20044351
[TBL] [Abstract][Full Text] [Related]
29. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
Loder MK; da Silva Xavier G; McDonald A; Rutter GA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
[TBL] [Abstract][Full Text] [Related]
30. Impact of transcription factor 7-like 2 (TCF7L2) on pancreatic islet function and morphology in mice and men.
Renström E
Diabetologia; 2012 Oct; 55(10):2559-2561. PubMed ID: 22864463
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
[TBL] [Abstract][Full Text] [Related]
32. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.
Tong Y; Lin Y; Zhang Y; Yang J; Zhang Y; Liu H; Zhang B
BMC Med Genet; 2009 Feb; 10():15. PubMed ID: 19228405
[TBL] [Abstract][Full Text] [Related]
33. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
[TBL] [Abstract][Full Text] [Related]
34. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population.
Horikoshi M; Hara K; Ito C; Nagai R; Froguel P; Kadowaki T
Diabetologia; 2007 Apr; 50(4):747-51. PubMed ID: 17245589
[TBL] [Abstract][Full Text] [Related]
35. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
36. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
Kimber CH; Doney AS; Pearson ER; McCarthy MI; Hattersley AT; Leese GP; Morris AD; Palmer CN
Diabetologia; 2007 Jun; 50(6):1186-91. PubMed ID: 17429603
[TBL] [Abstract][Full Text] [Related]
37. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals.
Guo T; Hanson RL; Traurig M; Muller YL; Ma L; Mack J; Kobes S; Knowler WC; Bogardus C; Baier LJ
Diabetes; 2007 Dec; 56(12):3082-8. PubMed ID: 17909099
[TBL] [Abstract][Full Text] [Related]
38. Review of the neuroanatomic landscape implicated in glucose sensing and regulation of nutrient signaling: immunophenotypic localization of diabetes gene Tcf7l2 in the developing murine brain.
Weaver C; Turner N; Hall J
J Chem Neuroanat; 2012 Oct; 45(1-2):1-17. PubMed ID: 22796301
[TBL] [Abstract][Full Text] [Related]
39. TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus.
Kovacs P; Berndt J; Ruschke K; Klöting N; Schön MR; Körner A; Stumvoll M; Blüher M
Metabolism; 2008 Sep; 57(9):1227-31. PubMed ID: 18702948
[TBL] [Abstract][Full Text] [Related]
40. Translating TCF7L2: from gene to function.
Pearson ER
Diabetologia; 2009 Jul; 52(7):1227-30. PubMed ID: 19387612
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
